This could be why your weight-loss medication isn’t delivering results

Scroll

A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like semaglutide and tirzepatide.

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America

Bias: right

0/500

Note: Comments are moderated. Please keep it civil. Max 3 comments per day.

No recent articles found in this language.